0
Review ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Human Health Effects Policy & Risk Remediation Sign in to save

Year in Review 2024: Noteworthy Literature in Cardiac Anesthesiology

Seminars in Cardiothoracic and Vascular Anesthesia 2025 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 53 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Tamás Seres, Barbara Wilkey, Nathaen Weitzel, Nathan Clendenen

Summary

This annual review of noteworthy cardiac anesthesiology literature from 2024 covered advances in devices, gene therapy, and transcatheter valve techniques across 447 articles. Among the emerging themes, the review noted the emerging risk of microplastic exposure in cardiovascular events, alongside developments in mechanical circulatory support, anti-inflammatory medications, and implantable wireless devices.

The research findings relevant for Cardiac Anesthesiology studies published in 2024 involved key innovations in devices and gene therapy in addition to the expansion of transcatheter techniques for valve repair or replacement. We reviewed 447 relevant articles and selected 21 as the most noteworthy studies published in 2024. Themes that emerged from our review include the etiology and prevention of delirium or outcomes after mechanical circulatory support. Robust clinical outcome data now supports the use of microaxial flow devices for mechanical circulatory support for cardiogenic shock due to acute myocardial infarction. Pharmacology development presents colchicine as anti-inflammatory medication to prevent atrial fibrillation or intravenous amino acids for kidney protection after cardiopulmonary bypass. Technological advances include implantable wireless pacing-defibrillator devices, pulmonary artery pressure monitoring in heart failure patients, extracorporeal blood purification for preventing acute kidney injury and hypothermic oxygenated perfusion of the donor heart in heart transplantation. Transcatheter interventions on mitral or aortic valve were gaining advances over surgical procedures. Novel paradigms included treatments with gene therapy for cardiac amyloidosis or refractory angina and the emerging risk of microplastic exposure in cardiovascular events.

Sign in to start a discussion.

Share this paper